Given that one in two people will develop cancer in their lifetime, it’s in everyone’s interest to be up to speed on the ...

Docetaxel added to androgen deprivation therapy (ADT) was the most cost-effective first-line regimen for patients with ...

February's line-up of games for the PlayStation Plus catalog have leaked online, and include a major PS5 blockbuster. Daemon has all the details in your Daily Fix! Epstein files update: Lieu calls for ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

Using both PSMA PET and mpMRI before cognitive targeted biopsy improved specificity for clinically significant prostate cancer from 54.6% to 86.3%. For men undergoing evaluation for suspected prostate ...

The European Society for Medical Oncology has updated its clinical practice guidelines for the management of localised prostate cancer and biochemical recurrence, refining diagnostic pathways and ...

People with diabetes may experience changes in their urinary and digestive health, and research shows there may be different effects on the body impacting the development of prostate cancer. Diabetes ...

A major health update has been shared by the family of former president Joe Biden following the announcement of his aggressive prostate cancer diagnosis. Ashley Biden, the former president’s daughter, ...

Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of radiation treatment Monday, his office said. Biden underwent several weeks of ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...